Drug intelligence / Profile preview

mometasone furoate + azelastine

Development stage
Phase 3
Lead developer
Glenmark Pharmaceuticals
Modality
Small Molecules
Administration
Intranasal
01

Overview

Mometasone furoate + azelastine is a fixed-dose combination nasal spray used primarily for the treatment of allergic rhinitis, including both seasonal and perennial forms. It combines two active ingredients with complementary mechanisms of action. Mometasone furoate is a corticosteroid that reduces inflammation by inhibiting the production of inflammatory mediators such as prostaglandins, thereby relieving symptoms like swelling and itching. Azelastine is an antihistamine that acts as a histamine H1-receptor antagonist, blocking the effects of histamine released during allergic reactions to reduce sneezing, runny nose, and itching. This combination provides rapid and sustained relief from nasal allergy symptoms[1][5][8].

Brand names
Ryaltris-AZMontasense AZMomeflo AZAzenate MTRYMOMET AZ NASAL SPRAY
Other names
mometasone + azelastineazelastine + mometasone
02

Targets

GR (Glucocorticoid receptor)HRH1 (Histamine H1 Receptor)

Beyond the preview

Go deeper on mometasone furoate + azelastine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on mometasone furoate + azelastine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call